DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: Gilead
News
16.09.2020
-
Gilead Sciences is to acquire Immunomedics for approximately $21 billion. The deal, unanimously approved by both companies' boards of directors, will be funded by $15...
News
02.09.2020
-
The US Food and Drug Administration (FDA) has come under fire again as the federal health agency issued its third Emergency Use Authorization (EUA) for a Covid-19...
News
11.08.2020
-
After teaming up with Germany’s BioNTech to develop a vaccine for Covid-19, US drugs giant Pfizer is joining US Gilead Sciences on the therapeutic side. The biopharma...
News
30.07.2020
-
The European Commission has signed a €63 million contract with Gilead Sciences to deliver batches of Veklury, Gilead’s name for the antiviral remdesivir, to the EU’s 27...
News
09.07.2020
-
After it emerged last week that the US federal government had nailed down the lion’s share of the world’s supply of the antiviral remdesivir, Gilead Sciences’ new drug...
News
03.07.2020
-
As the global coronavirus pandemic shows no signs of abating, the US “America first” approach to preventing and treating Covid-19 has again provoked worldwide concern.
News
15.06.2020
- Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with Gilead Sciences. The agreement will grant Dr. Reddy’s the right to register, manufacture and sell...
News
09.06.2020
- Anglo-Swedish drugmaker AstraZeneca is weighing a merger with US biotech Gilead Sciences, the Bloomberg news agency has reported. Surpassing Bristol Myers Squibb’s $74 billion...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.